MoneyWorks4Me

Trident Lifeline completes acquisition of 50.49% stake in TLL Parenterals

03 Dec 2024 Evaluate

Trident Lifeline has completed acquisition of additional 50.49% of the total issued and paid-up share capital of TLL Parenterals (TPL), by way of new allotment of equity shares and making TPL as a subsidiary of the Company. 

This acquisition would allow the company to partner with the leading and fast-growing market of organic and inorganic chemicals along with pharmaceuticals and allied products.

Trident Lifeline is engaged in the manufacturing and marketing of quality finished dosages.

Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..